Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Discovery themes featuring this stock
Ambalal Sarabhai Enterprises Ltd (AMBALALSA) is currently trading at 31.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Ambalal Sarabhai Enterprises Ltd. is a pioneering company in pharmaceuticals and electronics manufacturing, operating domestically and internationally. ASE has a strong historical legacy, entering various technical collaborations and forming joint ventures to enhance its product offerings. The company recently expanded its oncology capabilities, launching a new synthetic API plant in Ranoli, Vadodara, in June 2023. ASE leverages strategic technology tie-ups to maintain a competitive edge in its sectors, focusing on innovative drug delivery systems. With a diversified portfolio, ASE is positioned to continue growth through its subsidiaries specializing in cutting-edge pharmaceutical and electronic products.
Over the past 52 weeks, Ambalal Sarabhai Enterprises Ltd has traded between a low of ₹23.12 and a high of ₹41.45. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Ambalal Sarabhai Enterprises Ltd has a market capitalization of approximately 246.61. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Ambalal Sarabhai Enterprises Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.14 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 246.61 Cr, Ambalal Sarabhai Enterprises Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Ambalal Sarabhai Enterprises Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Ambalal Sarabhai Enterprises Ltd is 21.14. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
355.00 | 255 Cr | 55.73 | 12.77 | 0.00 | 15.67 | 18.38 | 8.59 | ||
50.73 | 255 Cr | 36.40 | 2.09 | 0.00 | 4.78 | 5.68 | 4.50 | ||
10.45 | 253 Cr | 13.73 | 1.18 | 0.00 | 7.77 | 8.53 | 5.49 | ||
28.75 | 247 Cr | 21.14 | 1.67 | 0.00 | 10.60 | 10.22 | 4.24 | ||
84.65 | 240 Cr | 79.86 | 1.66 | 0.00 | 2.41 | 5.22 | 1.17 | ||
12.38 | 240 Cr | -0.68 | 0.34 | 0.00 | -18.17 | -14.48 | -19.57 | ||
163.05 | 238 Cr | 11.56 | 4.00 | 0.00 | 28.30 | 25.84 | 0.00 | ||
| Median: 7 Co. | — | 50.73 | 247 Cr | 21.14 | 1.67 | 0.00 | 7.77 | 8.53 | 4.24 |
Bearish
8
Neutral
3
Bullish
3
Bearish
9
Neutral
3
Bullish
34
Bearish
1
Neutral
0
Bullish
31
Ambalal Sarabhai Enterprises Ltd. is a pioneering company in pharmaceuticals and electronics manufacturing, operating domestically and internationally.
ASE has a strong historical legacy, entering various technical collaborations and forming joint ventures to enhance its product offerings.
The company recently expanded its oncology capabilities, launching a new synthetic API plant in Ranoli, Vadodara, in June 2023.
ASE leverages strategic technology tie-ups to maintain a competitive edge in its sectors, focusing on innovative drug delivery systems.
With a diversified portfolio, ASE is positioned to continue growth through its subsidiaries specializing in cutting-edge pharmaceutical and electronic products.
Pharmaceuticals & Biotechnology
Pharmaceuticals
247 Cr
Low Risk
21.1
32.2
0.5
1.7
41.45
23.12
Sales CAGR
Profit CAGR
ROE
ROCE
